Davidson B J, Spiro R H, Patel S, Patel K, Shah J P
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.
Am J Surg. 1994 Nov;168(5):395-9. doi: 10.1016/s0002-9610(05)80083-2.
We have updated our experience with metastatic carcinoma to the neck of occult origin to assess whether increasing use of adjunctive radiation therapy has had a significant impact.
This retrospective review of 115 patients treated between 1977 and 1990 includes 73 (63%) with squamous cell carcinoma. These 73 patients were analyzed for survival, control of disease in the neck, and incidence of subsequent primary tumors.
There has been no change in the proportion of patients with advanced neck disease (N2/N3 = 52; 71%) when compared to our last report. Surgery included comprehensive neck dissection in 59 (81%) and adjunctive radiotherapy was employed in 54 (83% of surgically treated patients). Primary carcinomas within the head and neck were identified subsequently in 9 (12%) patients, including 4 of 11 (36%) who did not have adjunctive radiotherapy and 5 of 54 (9%) who did (P = 0.038). Control of the treated neck (54/73; 74%) has improved significantly (P = 0.005) when compared to our earlier experience (37/74; 50%), and this was most apparent in those with extensive neck disease. However, cumulative survival at 5 years (45%) was not significantly different from that previously reported.
Our data support the increased use of adjunctive radiation therapy for metastatic squamous cell carcinoma in the neck of occult origin. Control of neck disease has improved and the likelihood that a primary will be identified has been reduced, but there has been no improvement in survival when compared to historical controls.
我们更新了隐匿性原发灶转移至颈部的癌的治疗经验,以评估辅助放疗使用的增加是否产生了显著影响。
对1977年至1990年间治疗的115例患者进行回顾性研究,其中73例(63%)为鳞状细胞癌。对这73例患者的生存情况、颈部疾病控制情况以及后续原发肿瘤的发生率进行了分析。
与我们上次报告相比,晚期颈部疾病患者(N2/N3 = 52;71%)的比例没有变化。手术包括59例(81%)的根治性颈清扫术,54例(手术治疗患者的83%)采用了辅助放疗。随后在9例(12%)患者中发现了头颈部原发性癌,其中11例未接受辅助放疗的患者中有4例(36%),接受辅助放疗的54例患者中有5例(9%)(P = 0.038)。与我们早期的经验(37/74;50%)相比,治疗颈部的控制情况(54/73;74%)有显著改善(P = 0.005),这在颈部疾病广泛的患者中最为明显。然而,5年累积生存率(45%)与之前报告的没有显著差异。
我们的数据支持增加对隐匿性原发灶转移至颈部的鳞状细胞癌使用辅助放疗。颈部疾病的控制得到了改善,发现原发性癌的可能性降低了,但与历史对照相比,生存率没有提高。